We hypothesize that rectal NSAID prophylaxis use will have significantly risen in comparison to the 2013 survey. We hypothesize biliary endoscopists will show a significantly better risk factor recognition than general gastroenterologists. We…
ID
Bron
Verkorte titel
Aandoening
Post-ERCP pancreatitis
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
The primary outcome measure of this survey is exploration of the use and attitudes towards various forms of post-ERCP prophylaxis (NSAID use, prophylactic PD-stenting and IV hyperhydration) amongst Dutch biliary endoscopists.
Achtergrond van het onderzoek
Post-ERCP pancreatitis (PEP) is the most common complication of an endoscopic retrograde cholangiopancreaticography (ERCP), with serious risks of severe morbidity and mortality.
Various prophylactic measures for the prevention of PEP have been studied and implemented over the past years, namely rectal NSAID administration, prophylactic pancreatic duct (PD) stenting and intravenous hyperhydration. Practice differs between physicians worldwide, this has been demonstrated in earlier surveys on the subject. Numbers have not earlier been published on the practice of Dutch gastro-enterologists.
This survey is initiated by the Dutch Pancreatitis Study Group (DPSG) in order to establish the current clinical practice in the use of post-ERCP pancreatitis prophylaxis and recognition of risk factors for PEP amongst Dutch gastro-enterologists. The survey, which will be sent to Dutch gastroenterologists, consists of 47 questions on the various types of prophylaxis and possible risk factors. The primary outcome measure is exploration of the use of various forms of post-ERCP prophylaxis (NSAID use, prophylactic PD-stenting and IV hyperhydration) amongst Dutch biliary endoscopists. Secondary outcome measures are recognition of risk factors for PEP, guideline adherence, presence of PEP prophylaxis protocol and longitudinal comparison with 2013 survey.
This survey will give more clarity on current clinical practice in post-ERCP pancreatitis prophylaxis use and identify knowledge gaps between the clinical practice and guideline recommendations.
Doel van het onderzoek
We hypothesize that rectal NSAID prophylaxis use will have significantly risen in comparison to the 2013 survey.
We hypothesize biliary endoscopists will show a significantly better risk factor recognition than general gastroenterologists.
We hypothesize risk factors for post-ERCP pancreatitis will be recognized significantly more accurate than in the 2013 survey.
Onderzoeksopzet
N/A
Onderzoeksproduct en/of interventie
Online survey
Publiek
Wetenschappelijk
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
BIG-registered physician specialized in gastroenterology
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Non- gastroenterology physicians
2. Residents
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Toelichting
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL8493 |
| Ander register | Radboud CMO : 2020-6375 |